These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 35038138)
1. Atrial fibrillation as a precursor of mRNA-1273 SARS-CoV-2 vaccine-induced pericarditis. Scheuermeyer FX; Yoo J; Greene M; O'Donnell S CJEM; 2022 Mar; 24(2):230-232. PubMed ID: 35038138 [No Abstract] [Full Text] [Related]
2. Myocarditis after vaccination against covid-19. Gellad WF BMJ; 2021 Dec; 375():n3090. PubMed ID: 34916217 [No Abstract] [Full Text] [Related]
3. SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study. Husby A; Hansen JV; Fosbøl E; Thiesson EM; Madsen M; Thomsen RW; Sørensen HT; Andersen M; Wohlfahrt J; Gislason G; Torp-Pedersen C; Køber L; Hviid A BMJ; 2021 Dec; 375():e068665. PubMed ID: 34916207 [TBL] [Abstract][Full Text] [Related]
4. [Pericarditis after administration mRNA COVID-19 vaccine]. Díaz R F; Ampuero A C; Donoso F A Andes Pediatr; 2021 Dec; 92(6):973-975. PubMed ID: 35506812 [No Abstract] [Full Text] [Related]
5. Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination - PCORnet, United States, January 2021-January 2022. Block JP; Boehmer TK; Forrest CB; Carton TW; Lee GM; Ajani UA; Christakis DA; Cowell LG; Draper C; Ghildayal N; Harris AM; Kappelman MD; Ko JY; Mayer KH; Nagavedu K; Oster ME; Paranjape A; Puro J; Ritchey MD; Shay DK; Thacker D; Gundlapalli AV MMWR Morb Mortal Wkly Rep; 2022 Apr; 71(14):517-523. PubMed ID: 35389977 [TBL] [Abstract][Full Text] [Related]
6. COVID-19 vaccines surveillance in France: a global response to a major national challenge. Benkebil M; Gautier S; Gras-Champel V; Massy N; Micallef J; Valnet Rabier MB Anaesth Crit Care Pain Med; 2021 Jun; 40(3):100866. PubMed ID: 33895471 [No Abstract] [Full Text] [Related]
7. Sensitization to trometamol in patients with delayed local reactions after administration of the Moderna mRNA-1273 vaccine against SARS-CoV-2. Davila-Fernandez G; Sanchez-Moreno GV; Madrigal-Burgaleta R J Allergy Clin Immunol Pract; 2022 Aug; 10(8):2166-2168.e1. PubMed ID: 35513307 [No Abstract] [Full Text] [Related]
8. Meta-Analysis of Risk of Myocarditis After Messenger RNA COVID-19 Vaccine. Wang M; Wen W; Zhou M; Wang C; Feng ZH Am J Cardiol; 2022 Mar; 167():155-157. PubMed ID: 35063268 [No Abstract] [Full Text] [Related]
9. Myocarditis and Pericarditis After Vaccination for COVID-19. Diaz GA; Parsons GT; Gering SK; Meier AR; Hutchinson IV; Robicsek A JAMA; 2021 Sep; 326(12):1210-1212. PubMed ID: 34347001 [TBL] [Abstract][Full Text] [Related]
10. Aortic Mural Thrombosis Diagnosed After a Second Dose of mRNA-1273 SARS-CoV-2 Vaccine. Punjwani S; Khanna P; Jani C; Waston J; Behlau I Am J Ther; 2022 May-Jun 01; 29(3):e358-e361. PubMed ID: 35533327 [No Abstract] [Full Text] [Related]
13. Response to: Skin reactions to mRNA-1273 SARS-CoV-2 vaccine. Kano Y; Kasami S; Murata K; Kato M QJM; 2022 Dec; 115(12):879. PubMed ID: 35038737 [No Abstract] [Full Text] [Related]
14. Incident bullous pemphigoid in a psoriatic patient following mRNA-1273 SARS-CoV-2 vaccination. Hung WK; Chi CC J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):e407-e409. PubMed ID: 35073431 [No Abstract] [Full Text] [Related]
15. Guillain-Barrè syndrome following COVID-19 vaccine mRNA-1273: a case report. Masuccio FG; Comi C; Solaro C Acta Neurol Belg; 2022 Oct; 122(5):1369-1371. PubMed ID: 34767184 [No Abstract] [Full Text] [Related]
16. Development of pemphigus vulgaris after the second dose of the mRNA-1273 SARS-Cov-2 vaccine. Koutlas IG; Camara R; Argyris PP; Davis MDP; Miller DD Oral Dis; 2022 Nov; 28 Suppl 2():2612-2613. PubMed ID: 34825752 [No Abstract] [Full Text] [Related]
17. Vasculitic flare in a patient with anti-myelin-associated glycoprotein (MAG) antibody following mRNA-1273 SARS-CoV-2 vaccine. Briani C; Ferrari S; Tagliapietra M; Trentin L; Visentin A J Neurol; 2023 Mar; 270(3):1207-1210. PubMed ID: 36355184 [No Abstract] [Full Text] [Related]
18. [Pleuropericardial effusion and systemic inflammatory syndrome secondary to the administration of the mRNA-1273 vaccine for SARS-CoV-2]. Boira I; Torba A; Castelló C; Esteban V; Vañes S; Chiner E Arch Bronconeumol; 2022 Apr; 58(4):372-373. PubMed ID: 35017783 [No Abstract] [Full Text] [Related]
19. Definite Acute Myocarditis After Coronavirus Disease 2019 mRNA Vaccination. Maeda M; Isawa T; Tada N Circ J; 2022 Mar; 86(4):724. PubMed ID: 34866122 [No Abstract] [Full Text] [Related]
20. Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine. Holzworth A; Couchot P; Cruz-Knight W; Brucculeri M Kidney Int; 2021 Aug; 100(2):463-464. PubMed ID: 34048824 [No Abstract] [Full Text] [Related] [Next] [New Search]